No telomere shortening in marrow stroma from patients with MDS. - Wikidata - awgldk - TriplyDB

No telomere shortening in marrow stroma from patients with MDS.

No telomere shortening in marrow stroma from patients with MDS.

http://www.wikidata.org/entity/Q37219621

about

Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency.Stress responsive biochemical anabolic/catabolic ratio and telomere length in older adults.Telomere length in myelodysplastic syndromes.Abnormal mRNA Expression Levels of Telomere-Binding Proteins Represent Biomarkers in Myelodysplastic Syndromes: A Case-Control Study Mesenchymal stem cells in immune-mediated bone marrow failure syndromes.

P2860

Q33733541-62663D39-8030-43A9-8854-F5872D57BEF3 Q34193321-B65B7F8E-B842-4EE5-9852-841B7604F7A1 Q34544862-9679A1A2-C7FE-4C45-A7E7-BB2903775B3B Q35136851-ECB756B7-E326-4CDA-9459-A60BEF1A1DE1 Q35141577-6D115CE4-3FF3-4200-B285-91F02FE96E1F Q35150727-2D3D8806-09CD-4E3D-8E98-B31C432ED081 Q36345275-F5FC1A7D-D112-4081-B129-8D867C05438F Q38175397-32CAEE5F-0E93-4B61-B13B-77BE08094D94

P2860

No telomere shortening in marrow stroma from patients with MDS.

http://www.wikidata.org/entity/Q37219621

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

No telomere shortening in marrow stroma from patients with MDS.

@en

No telomere shortening in marrow stroma from patients with MDS.

@nl

type

label

No telomere shortening in marrow stroma from patients with MDS.

@en

No telomere shortening in marrow stroma from patients with MDS.

@nl

prefLabel

No telomere shortening in marrow stroma from patients with MDS.

@en

No telomere shortening in marrow stroma from patients with MDS.

@nl

P1433

Q37219621-381018A4-8D55-4B3B-99AA-D5C8E00884ED

P1476

Q37219621-29427C90-5B9F-421C-8530-1729D714AC6A

P2093

Q37219621-56EEE1AB-E309-476E-95C3-51433266E692

Q37219621-83CBA0CA-905A-4B73-9E45-769DA872FFC2

Q37219621-C5BD984B-10E3-454B-A7B0-A2BE18D7B1C2

Q37219621-F867B047-9CA9-4FEB-977B-2BCE3A9C276E

P2860

Q37219621-01F3E99E-B667-4143-B757-46D038490D2C

Q37219621-0CAB7607-533E-4306-8B5F-CA92E6872410

Q37219621-18C2C07F-81AA-46F3-8C72-8A58DA280D50

Q37219621-3D795D35-15D6-4C09-9212-CCCD6359C12C

Q37219621-41B9FDBA-AD5D-47B8-8A67-87EAC4C006F5

Q37219621-4200967A-4792-4239-9CEE-D737767B66A0

Q37219621-5003019A-E138-47F9-AED3-8DC8EB307D7A

Q37219621-50977205-7E10-4DDC-AFEB-45BBFC91C763

Q37219621-8113E97D-45C6-4364-9DC7-786C154F4E17

Q37219621-8F45D909-CAF4-4FC0-AFB7-572C7D4045C5

P304

Q37219621-2F6E6BF8-FD54-4712-A353-681D257F16FB

P31

Q37219621-48B97F5E-A554-4293-843A-2B1B61243CD7

P356

Q37219621-85FF4069-FA8C-47B9-B035-1FB8E23447EA

P433

Q37219621-A0733156-A829-4366-B9C4-2F5BA2ABC44C

P478

Q37219621-DACC7C09-DFA5-4C05-907A-7E5874A4AD0E

P50

Q37219621-7AA0076B-73BC-4DFB-83C0-B41E07774915

Q37219621-BEC1C47C-2F3A-4092-A2BE-DC25546C8176

P577

Q37219621-3DACD508-9ABD-485B-B2B1-660A501DE7BB

P5875

Q37219621-B64B381E-0D96-4111-BFEB-09566F900F32

P698

Q37219621-86F1E9FC-CB70-44AF-BE8A-E11D034C0ED6

P932

Q37219621-4DFBAF06-99C5-4F05-B294-1F20AFD0AB51

P356

S00277-008-0649-7

P1433

Annals of Hematology

P1476

No telomere shortening in marrow stroma from patients with MDS

@en

P2093

A Mario Marcondes

http://www.w3.org/2001/XMLSchema#string

H Joachim Deeg

http://www.w3.org/2001/XMLSchema#string

Rosana Risques

http://www.w3.org/2001/XMLSchema#string

Ted Gooley

http://www.w3.org/2001/XMLSchema#string

P2860

International scoring system for evaluating prognosis in myelodysplastic syndromes

Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice.

Connecting chromosomes, crisis, and cancer.

Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation.

The extent and significance of telomere loss with age.

Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function

Telomere dynamics in myelodysplastic syndrome determined by telomere measurement of marrow metaphases.

Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?

Leukocyte telomere length predicts cancer risk in Barrett's esophagus.

Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro.

P304

623-628

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-008-0649-7

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

P S Rabinovitch

P577

2008-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227294886

http://www.w3.org/2001/XMLSchema#string

P698

19050887

http://www.w3.org/2001/XMLSchema#string

P932

2693355

http://www.w3.org/2001/XMLSchema#string